Overview

A Study to Assess the Effect of Single Doses of Daridorexant on Electrocardiogram Parameters in Healthy Subjects

Status:
Completed
Trial end date:
2020-07-22
Target enrollment:
Participant gender:
Summary
A study to assess the effect of single doses of daridorexant on electrocardiogram parameters in healthy subjects
Phase:
Phase 1
Details
Lead Sponsor:
Idorsia Pharmaceuticals Ltd.
Treatments:
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination